Mallinckrodt Public Profile

13.76
USD 0.28  1.99%
0%
46%

Mallinckrodt Public exotic insider transaction detected

Mallinckrodt Public Limited Company insider trading alert for general transaction of ordinary shares by Lannum Coleman N Iii, VP Investor Relations, on April 21, 2018. This event was filed by Mallinckrodt Plc with SEC on 2015-04-02. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Mallinckrodt Public Summary

Mallinckrodt Public Limited Company (MNK) is traded on New York Stock Exchange in USA. It is located in IRELAND and employs 3,900 people. Mallinckrodt Public is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Mid-Cap' category with total capitalization of 1.21 B. Mallinckrodt Public Limited Company runs under Healthcare sector within Pharmaceuticals And Biosciences industry. This company has 86.39 M outstanding shares of which 22.29 M shares are now shorted by investors with about 4.76 days to cover shorted positions. ML NIKKEI225 MITT has about 1.26 B in cash with 727.3 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 14.6 which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Mallinckrodt Public Probability Of Bankruptcy

Ownership Allocation (%)

Target Price Odds Analysis

Below OddsHorizonTargetAbove Odds
about 10.84%30 days 13.76  about 89.09%
Based on normal probability distribution, the odds of Mallinckrodt Public to move above current price in 30 days from now is about 89.09% (This Mallinckrodt Public Limited Company probability density function shows the probability of Mallinckrodt Public Stock to fall within a particular range of prices over 30 days) .

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
First Quadrant L PCommon Shares103.4 K1.5 M
Acadian Asset Management LlcCommon Shares86 K1.2 M
View Mallinckrodt Public Diagnostics

Selected Mallinckrodt Public Limited Company Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Mallinckrodt Public Against Markets

Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
Financial Distress (0 to 100%)
< 52% 
Equity ratings for Mallinckrodt Public Limited Company are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Mallinckrodt public limited company develops, manufactures, markets, and distributes branded pharmaceutical products in Canada and the European Union, as well as in Latin American, the Middle Eastern, African, and the Asia-Pacific regions. The company is based in Staines-Upon-Thames, the United Kingdom. Mallinckrodt Public operates under Drug Manufacturers - Specialty Generic classification in USA and traded on New York Stock Exchange. It employs 00 people. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameMallinckrodt Public Limited Company
CEOMark TrudeauView All
Thematic Classification
Currently Active Investing Idea
  Obamacare Repeal
View All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Bond Rating
Specialization
Healthcare, Pharmaceuticals And Biosciences
InstrumentUSA Stock View All
LocationIRELAND
Business Address3 Lotus Park
ExchangeNew York Stock Exchange
ISINIE00BBGT3753
CUSIPG5785G107
SectorHealthcare
IndustryPharmaceuticals And Biosciences
BenchmarkDOW
Websitewww.mallinckrodt.com
Contact Number44 17 8463 6700
CurrencyUSD - US Dollar

Recommendations

Mallinckrodt Public Analyst Recommendations
Target PriceAdvice# of Analysts
78.31Buy13Odds
Mallinckrodt Public Limited Company current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Mallinckrodt Public Analyst Advice  

Earnings

Mallinckrodt Public Earnings Estimates
EPSEstimate Date
Quarterly Estimate1.64May 2, 2017
Mallinckrodt Public Limited Company normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  

Directors

Mallinckrodt Public Corporate Directors
David Carlucci Independent Director
Martin Carroll Independent Director, MBA
Kneeland Youngblood Independent Director, Ph.D
Please see also Stocks Correlation. Please also try Money Managers module to screen money managers from public funds and etfs managed around the world.